Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OM85 for Prevention of Respiratory Events in Health Care Workers During COVID-19
NCT04496245Phase 3Completed
- Sponsor
- The University of Queensland
- Start
- Aug 2020
- Primary completion
- Jun 2021
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of OM-85 in coronavirus disease 2019 (COVID-19), Acute Respiratory Infection (ARI), sponsored by The University of Queensland. Started Aug 2020; status: completed.
02
Drugs
OM-85
03
Conditions
coronavirus disease 2019 (COVID-19)Acute Respiratory Infection (ARI)
Beyond the preview
Go deeper on NCT04496245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04496245.